Category Archives: TB

AMPATH builds comprehensive health care services for Kenyans on PEPFAR platform

By on .

During a recent visit to Kenya with a group of Capitol Hill staff from key Congressional offices, Center for Global Health Policy Director Christine Lubinski toured AMPATH – a consortium that has created a broad range of health care services and programs with strong community engagement in Western Kenya. This post describes their extensive services…

PEPFAR 2012 Country Operational Guidance includes special section on HIV/TB

By on .

Part of the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) program’s recently released 2012 Country Operational Plan Guidance, the TB/HIV Technical Considerations highlight the important role of tuberculosis prevention and treatment in successfully combating the HIV pandemic. The updated “considerations” take into account the 2011 World Health Organization (WHO) “Guidelines for intensified tuberculosis case-finding […]

Evidence mounts against use of antibody-based blood tests to detect active TB

By on .

Two articles that went live on the PLoS Medicine journal website Tuesday afternoon further explain the reasoning behind the World Health Organization’s (WHO) July 20th statement urging countries to ban blood tests for active tuberculosis (TB) and instead rely on accurate microbiological or molecular tests, as they recommend. Originally thought to be a small problem confined to few countries, further research has found that the inaccurate and unapproved blood tests for active TB are much more widely used, making the potential risk of false negatives and false positives much higher than anticipated. Moreover, the tests are not cost-effective as compared to other available TB tests…

Cepheid fares well with sales of rapid TB test in developing countries

By on .

Producer of the rapid TB diagnostic GeneXpert, Cepheid recently announced its 2011 second quarter profits in an earnings report and subsequent public conference call. Revenues for the quarter reached $67 million, an increase of 11 percent from the previous quarter and 35 percent from the second quarter of 2010. Cepheid is now projecting revenues of $265 to $270 million for all of 2011, $15 to $20 million above its previous projections…